𝔖 Bobbio Scriptorium
✦   LIBER   ✦

American association for the study of liver diseases post graduate course


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
233 KB
Volume
10
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The American Association for the Study o
✍ Hyman J. Zimmerman; Leonard B. Seeff πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 317 KB πŸ‘ 1 views

As the official journal of the American Association for the Study of Liver Diseases, Hepatology is privileged to publish selected acknowledgments of major contributions made to the field of liver disease, such as those of Hyman J. Zimmerman. ## "Lives of great men all remind us We can make our li

Diagnosis and management of hemochromato
✍ Bruce R. Bacon; Paul C. Adams; Kris V. Kowdley; Lawrie W. Powell; Anthony S. Tav πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 374 KB πŸ‘ 1 views

This guideline has been approved by the American Association for the Study of Liver Diseases (AASLD) and represents the position of the association. ## Preamble These recommendations provide a data-supported approach to establishing guidelines. They are based on the following: (1) a formal review

Portal hypertension and variceal bleedin
✍ Guadalupe Garcia-Tsao; Jaime Bosch; Roberto J. Groszmann πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 119 KB

any randomized controlled trials (RCTs) have advanced the knowledge of the complications of portal hypertension, specifically in the management of varices and variceal hemorrhage. The endpoints in most of these trials have used definitions attained at international consensus workshops that have been

American association for the study of li
✍ Marina G. Silveira; Elizabeth M. Brunt; Jenny Heathcote; Gregory J. Gores; Keith πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 143 KB πŸ‘ 1 views

A group of multidisciplinary experts on primary biliary cirrhosis (PBC) and its complications convened on May 31, 2009, under the aegis of the American Association for the Study of Liver Diseases (AASLD) in order to identify the most appropriate design and endpoints for clinical trials of PBC based